CN113855766A - Gingko and cordyceps militaris granules capable of regulating blood pressure - Google Patents
Gingko and cordyceps militaris granules capable of regulating blood pressure Download PDFInfo
- Publication number
- CN113855766A CN113855766A CN202111174479.7A CN202111174479A CN113855766A CN 113855766 A CN113855766 A CN 113855766A CN 202111174479 A CN202111174479 A CN 202111174479A CN 113855766 A CN113855766 A CN 113855766A
- Authority
- CN
- China
- Prior art keywords
- parts
- cordyceps militaris
- blood
- blood pressure
- gingko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 33
- 244000194101 Ginkgo biloba Species 0.000 title claims abstract description 29
- 230000036772 blood pressure Effects 0.000 title claims abstract description 18
- 239000008187 granular material Substances 0.000 title claims abstract description 17
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 21
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 20
- 240000004371 Panax ginseng Species 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 17
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 16
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 11
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 11
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 11
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 11
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 10
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 10
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 10
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 10
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 10
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 10
- 235000005822 corn Nutrition 0.000 claims abstract description 10
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 8
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 244000182216 Mimusops elengi Species 0.000 claims abstract 4
- 230000000694 effects Effects 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004204 blood vessel Anatomy 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 15
- 230000001976 improved effect Effects 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 210000004165 myocardium Anatomy 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 230000008859 change Effects 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 206010047141 Vasodilatation Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000004220 muscle function Effects 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000024883 vasodilation Effects 0.000 abstract description 2
- 230000001133 acceleration Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 16
- 210000002216 heart Anatomy 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 240000002624 Mespilus germanica Species 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 150000002212 flavone derivatives Chemical class 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 210000001772 blood platelet Anatomy 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000004913 chyme Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- -1 flavonoids compounds Chemical class 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108010047320 Pepsinogen A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 240000000038 Ziziphus mauritiana Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 206010026820 marasmus Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000108 taste bud cell Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of health care, and particularly relates to a gingko and cordyceps militaris granule capable of regulating blood pressure, which comprises the following formula raw materials: ginkgo powder, Chinese date, cordyceps militaris, ginseng, medlar, white gourd, cassia seed, kudzu root, chrysanthemum, Chinese yam, corn stigma, sealwort, gardenia, hawthorn, mint, maltodextrin and citric acid. The invention skillfully utilizes the effects of promoting blood circulation and removing blood stasis of various components in the formula, can effectively clear and dredge blood vessels, change microcirculation, recover the elasticity of blood vessels, and clear harmful substances accumulated in the blood vessels for a long time, fully utilizes the convenience characteristic of the medicinal granules, is convenient to take and drink after being infused in water, is convenient for full utilization and absorption of human bodies, exerts synergistic effect among the components to form mutual complementary, can obviously feel improved energy and improved immunity after being absorbed by the human bodies, increases the cardiac muscle function, promotes vasodilatation, promotes the acceleration of blood circulation and blood circulation smoothness, is convenient to use, adopts the medicinal and edible nutrition without toxic and side effects, and is suitable for long-term drinking.
Description
Technical Field
The invention relates to the technical field of health care, in particular to ginkgo and cordyceps militaris granules capable of regulating blood pressure.
Background
Investigation finds that along with the improvement of living standard of people, people are often busy with remuneration, have unreasonable dietary structure and are not controlled, and are in a high-oil, high-salt and high-sugar state for a long time, and high protein and high fat are excessively ingested, so that fat in blood vessels is increased; in addition, bad habits such as drinking and smoking or environmental pollution are added, so that more and more patients with cardiovascular diseases have a trend of being younger and younger.
The blood flows in the blood vessel of the human body like river water, and the faster the flow speed is, the less the sediment is; conversely, the slower the flow rate, the more sediment. The increase of blood viscosity will result in the slowing of blood flow speed, and the substances in blood, such as blood platelets, cholesterol, fibrin, and the like, will precipitate on the blood vessel wall, and over time, the more the precipitate is accumulated, and atherosclerosis is formed, and if hypertension, hyperlipidemia, and the like are combined, cerebral thrombosis, coronary heart disease, diabetes, and other diseases are easily caused.
In recent years, the morbidity and mortality of various cardiovascular diseases are on the rise, and more remarkably, the incidence and mortality of various cardiovascular diseases are not rare for young and old people. Therefore, it is necessary to improve immunity and promote blood circulation in daily life to reduce the incidence of the above diseases. At present, most of the medicines for prevention in the market have large side effects, and long-time eating of the medicines has certain harm to human bodies and is inconvenient for long-time eating.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides ginkgo cordyceps militaris granules capable of conditioning blood pressure, and solves the problems that most of medicines for prevention in the market have large side effects, and long-time eating of the medicines has certain harm to human bodies and is inconvenient for long-time eating.
(II) technical scheme
The invention specifically adopts the following technical scheme for realizing the purpose:
a gingko and cordyceps militaris granule capable of regulating blood pressure comprises the following formula raw materials: ginkgo powder, Chinese date, cordyceps militaris, ginseng, medlar, white gourd, cassia seed, kudzu root, chrysanthemum, Chinese yam, corn stigma, sealwort, gardenia, hawthorn, mint, maltodextrin and citric acid.
Further, the formula comprises the following components in parts by weight: 10 parts of ginkgo powder, 5 parts of Chinese date, 11 parts of cordyceps militaris, 10 parts of ginseng, 7 parts of medlar, 3 parts of white gourd, 3 parts of cassia seed, 6 parts of kudzu root, 6 parts of chrysanthemum, 5 parts of Chinese yam, 2 parts of corn stigma, 1 part of rhizoma polygonati, 1 part of gardenia, 1 part of hawthorn, 0.5 part of mint, 0.1 part of maltodextrin and 0.1 part of citric acid.
Furthermore, the ginseng is artificially planted for five years or less.
Further, the formula comprises the following raw materials: the ginkgo powder, Chinese date, cordyceps militaris, ginseng, medlar, white gourd, cassia seed, kudzu root, chrysanthemum, Chinese yam, corn stigma, sealwort, gardenia, hawthorn and mint are dried and ground into powder.
The effects of the components in the invention are as follows:
ginkgo powder: the traditional Chinese medicine considers that the ginkgo leaves have sweet, bitter and astringent taste, and have the effects of benefiting the heart, astringing the lung, eliminating dampness, stopping diarrhea and the like. The main pharmacological actions are as follows: (health care), promoting blood circulation, and preventing cardiovascular and cerebrovascular diseases caused by hyperglycemia: the components of the ginkgo leaf extract are analyzed, and the flavone body, the biflavonoid body, the ginkgolide compound and other components in the ginkgo leaf can activate the platelet function, prevent blood from coagulating into blocks, and simultaneously can dilate blood vessels to promote the blood circulation of arteries and veins, thereby preventing cardiovascular diseases, cerebral thrombosis and apoplexy. (b) The memory is improved, and the senile dementia caused by hyperglycemia is prevented: as people age, the amount of secretion conducted by nerve material tends to decrease, resulting in decreased sensitivity and memory deterioration. The ginkgo can increase the content of a nerve conduction substance dopamin (dop health care mine) in a body, the dopamin can improve the capability of body communication information, and for the elderly with deteriorated intelligence function, the ginkgo can improve the mental activity capability of the elderly and prevent the occurrence of senile dementia. (c) Ginkgo biloba prevents platelet adhesion and aggregation caused by hyperglycemia, thereby preventing the formation of blood clots that can lead to heart attack or stroke, which can lead to heart attack if blood clots are present in the arteries leading to the heart; if a blood clot remains in an artery leading to the brain for a long period of time, a stroke can result. The above effects of folium Ginkgo can prevent diabetic complications and improve nerve and blood vessel functions.
Chinese date: sweet in taste, warm in nature, and capable of entering spleen and stomach channels, and has the functions of tonifying middle-jiao and Qi, nourishing blood and tranquilization and moderating drug property; modern pharmacology finds that the red dates contain rich nutritional ingredients such as proteins, saccharides, organic acids, vitamin A, vitamin C, various trace calcium, amino acids and the like; has ideal effects of treating the increase of serum transaminase of patients with allergic purpura, anemia, hypertension, acute and chronic hepatitis and liver cirrhosis, preventing blood transfusion reaction and the like; the Chinese date contains triterpenes and cyclic adenosine monophosphate, and has strong cancer inhibiting and antiallergic effects. The fructus Jujubae contains anti-fatigue substances, and has effects of enhancing human endurance, and relieving liver damage caused by toxic substances. The flavonoids compounds in fructus Jujubae have tranquilizing and blood pressure lowering effects.
Cordyceps militaris: the main chemical components and health care functions of the cordyceps militaris are similar to those of natural cordyceps sinensis, the cordyceps militaris has the functions of relieving asthma and cough, strengthening yang and tonifying kidney, has better curative effects on emphysema and tracheitis, has the obvious functions of reducing blood sugar and urine sugar, reducing blood pressure and intracranial pressure, and also has the functions of resisting bacteria and cancers, enhancing the immune function, moistening the muscles, beautifying the face, eliminating butterfly spots and the like. Clinical studies show that the average serum total cholesterol of patients can be reduced by 17.5 percent (the serum total cholesterol of a control group is reduced by 1.2 percent) before treatment by taking the cordyceps militaris; triglyceride reduction 9.9% (control 6.7%); high density lipoprotein cholesterol (HKLC) was elevated by 27.2% (10.4% in the control group), indicating a more reliable cholesterol lowering effect and an increase in HDL-C. The cordyceps militaris used by Jiangxi pharmaceutical factories is used for 5 hospitals to treat 117 cases of chronic bronchitis and clinical verification is carried out, the result shows that the significant efficiency is 49.6%, the improvement rate is 33.3%, and the total effective rate reaches 82.9%. The cordyceps militaris is used for treating 50 cases of impotence patients by Suzhou medical college-attach college, the total effective rate is 64 percent, both 17-hydroxy and 17-ketone are increased, and the cordyceps militaris is considered to have the functions of improving the function of adrenal cortex, tonifying kidney and strengthening yang and treating impotence. According to the results of 30 cases of chronic renal failure treated by cordyceps militaris in an equal report, after one month of treatment, the renal function of a patient is obviously improved, creatinine and urea in blood after treatment are obviously reduced compared with those before treatment, the creatinine clearance rate is improved, and hemoglobin is increased. 256 cases of chronic viral hepatitis treated by cordyceps militaris in Shanghai and the like have the effective rate of over 80 percent, symptoms, physical signs and liver functions of most patients are improved to different degrees, and the change of serum albumin and SGPT is obvious. The functions of the cordyceps militaris can also prevent and treat complications such as heart, liver, lung, kidney and sexual dysfunction caused by diabetes.
Ginseng: is suitable for regulating blood pressure, recovering heart function, neurasthenia and asthenia, and has expectorant, stomach invigorating, diuretic, and exciting effects; ginseng radix has effects of improving heart contractility and frequency, exciting heart, accelerating blood flow, promoting metabolism, regulating organism nutrition status, relieving physical decline, and enhancing resistance. Ginsenoside can activate phospholipid protease and promote phospholipid biosynthesis, thereby preventing atherosclerosis of coronary artery and heart aorta. Ginseng radix has certain curative effect on various heart diseases (coronary heart disease, angina pectoris, myocardial malnutrition, etc.) and anemia.
Medlar: contains beta-carotene, xanthophyll, etc., and has effects of improving immunity, preventing tumor formation and atherosclerosis. The Chinese medicine considers that the medlar has sweet taste and mild nature, enters liver and kidney channels, and has the effects of tonifying qi and strengthening essence, nourishing liver and kidney, resisting aging, quenching thirst and warming body; has effects in enhancing nonspecific immunity.
White gourd: sweet taste and cold nature, and has the effects of clearing away heat, inducing diuresis and relieving swelling. The white gourd has low sodium content, and has good adjuvant treatment effect on arteriosclerosis, ascites due to cirrhosis, coronary heart disease, hypertension, nephritis, edema, and distention. The tartronic acid contained in the white gourd can effectively inhibit the conversion of saccharides into fat, and the white gourd does not contain fat and has low calorie, thereby having important significance for preventing the human body from being fat and helping the body building. The seeds and peel of wax gourd can also be used as medicine, and pulp and flesh of wax gourd have the effects of promoting urination, clearing heat, reducing phlegm, quenching thirst and the like. It can also be used for treating edema, phlegm asthma, summer heat, and hemorrhoid. The white gourd like the decoction with peel can achieve the effects of relieving swelling, promoting urination, clearing away summer-heat.
Cassia seed: bitter, sweet, salty and slightly cold in nature, entering liver, kidney and large intestine meridians; loosening bowel to relieve constipation, reducing blood lipid, improving eyesight, and treating constipation, hyperlipemia, and hypertension. Clearing liver-fire, improving eyesight, promoting diuresis, relaxing bowels, lowering blood pressure, and reducing blood lipid.
Kudzu root: the traditional Chinese medicine considers that the kudzuvine root has the effects of invigorating yang and relieving muscles, promoting eruption and stopping diarrhea, and relieving restlessness and quenching thirst, and can be used for treating typhoid fever, warm headache and stiff neck, dysphoria and thirst, diarrhea, dysentery, ecchymosis, hypertension, angina, deafness and the like. Modern medical research finds that the total flavone and puerarin in the root of kudzu vine have obvious effect of dilating coronary blood vessels, so that coronary blood flow is increased, and vascular resistance is reduced; the puerarin extract has obvious effect of resisting arrhythmia, and puerarin can obviously reduce the range of myocardial infarction; the pueraria flavonid and puerarin can reduce the total peripheral resistance of the heart, reduce the oxygen consumption of the myocardium, improve the working efficiency of the myocardium and improve the metabolism of infarcted myocardium; the total puerarin and puerarin in radix Puerariae can significantly reduce the activity of renin and angiotensin in blood plasma, and reduce blood pressure. Puerarin has obvious improvement effect on microcirculation disturbance, and is mainly characterized by increasing the amplitude of microvascular motion and improving local microvessel flow; the pueraria flavonid has the function of obviously expanding cerebral vessels and improving cerebral microcirculation and peripheral circulation; puerarin also can improve the blocking state of retinal vascular peripheral unit, thereby improving the visual function of diabetic patients. In addition, puerarin can also obviously inhibit the release of 5-HT in blood platelets induced by thrombin, and has the function of resisting thrombosis. The radix Puerariae total flavone and alcohol extract can improve cerebral cortex and hippocampal acetylcholine content of rat, and reduce activity of hippocampal acetylcholine transferase.
Chrysanthemum: it can disperse wind-heat, suppress liver yang, clear liver and improve vision, and can be used for treating wind-heat type common cold or warm disease, fever, slight aversion to wind-cold, headache, liver yang hyperactivity, headache vertigo, conjunctival congestion and swelling pain due to wind-heat attack or liver fire flaming upward, and dim eyesight due to deficiency of liver and kidney essence and blood. However, sang Ye has stronger action of dispelling wind-heat, clearing lung-heat and moistening dryness, cooling blood and stopping bleeding. Chrysanthemum has strong actions of pacifying liver, clearing liver and improving vision, and clearing heat and removing toxicity.
Chinese yam: sweet, warm, mild and nontoxic. Mainly treats the diseases of impairment, deficiency, shortness of breath, cold and heat, evil qi removal, middle warmer tonifying, qi and strength benefiting, muscle growth and yin strengthening. It can be taken for a long time, and has effects of improving hearing and eyesight, reducing weight, and prolonging life. This meridian. Mainly treating head and face wandering wind, head wind and eye glare, descending qi, stopping lumbago, treating asthenia, marasmus, filling five internal organs, and removing dysphoria. And (6) recording. Tonify the five consumptive diseases and seven injuries, remove cold wind, calm the heart, tranquilize mind, tonify heart qi deficiency and open up the heart hole for recording many events. And (6) screening. Strengthen tendons and bones, induce emission and induce amnesia. Daming. Replenishing kidney qi, strengthening spleen and stomach, stopping diarrhea, resolving phlegm and moistening skin and hair. Shizhen. The swelling and toxicity of raw pounded plaster can be dissipated. The process is Shaheng.
Corn silk: sweet and light taste, mild nature, and is beneficial to urination and detumescence; clearing liver-fire, promoting bile flow, and treating edema, dribbling urine, jaundice, cholecystitis, cholelithiasis, hypertension, diabetes, and galactostasis.
Rhizoma polygonati: sweet taste, mild nature, qi invigorating, yin nourishing, spleen invigorating, lung moistening, kidney invigorating, and can be used for treating deficiency of spleen qi and stomach qi, tiredness, debilitation, stomach yin deficiency, dry mouth, anorexia, lung deficiency, dry cough, hemoptysis, essence and blood deficiency, soreness of waist and knees, early white beard and hair, internal heat, diabetes, and can help medicine vigor and make it not greasy. .
Gardenia: bitter and cold, purging fire and relieving restlessness, clearing heat and promoting diuresis, cooling blood and removing toxicity; it has repercussive and analgesic effects, and can be used for treating vexation due to febrile disease, jaundice due to damp-heat, stranguria, hematemesis, epistaxis, conjunctival congestion, swelling and pain, pyocutaneous disease due to pathogenic fire, and sprain, contusion and pain.
Hawthorn fruit: the traditional Chinese medicine considers that the hawthorn can eliminate dyspepsia, disperse blood stasis, expel tapeworm, promote digestion, strengthen stomach, promote qi circulation and eliminate blood stasis, and can be used for treating meat food stagnation, gastric distention, diarrhea and dysentery abdominal pain, blood stasis amenorrhea, postpartum blood stasis, heart and abdomen stabbing pain, hernia pain and hyperlipidemia. Clinical research proves that the hawthorn can obviously reduce high serum cholesterol and triglyceride caused by hyperglycemia, and effectively prevent and treat atherosclerosis; the hawthorn can also strengthen heart and prevent angina by enhancing myocardial contractility, increasing cardiac output, expanding coronary artery blood vessels, increasing coronary blood flow, reducing myocardial oxygen consumption and the like. In addition, the total flavone in the hawthorn has the functions of expanding blood vessels and persistently lowering blood pressure; the total flavone contained in fructus crataegi also has effects of promoting blood circulation, dispelling blood stasis, improving microcirculation, increasing blood supply to heart and brain, and eliminating nervous and blood vessel pathological changes caused by hyperglycemia.
Mint: pungent taste, cold nature, wind-heat dispelling, heat clearing, head and eyes benefiting, sore throat promoting, eruption promoting, liver soothing, qi circulation promoting, wind-heat affection, headache, sore throat, food stagnation, flatulence, aphtha, toothache, scabies, urticaria, epidemic febrile disease onset, rubella pruritus, stagnation of qi due to depression of the liver, chest distress, hypochondriac pain.
Maltodextrin, 2: various starches are used as raw materials, and the starch is prepared by hydrolysis conversion, purification and drying under low-degree control through an enzymatic process. The raw materials are corn containing starch, rice and the like. Or refined starch such as corn starch, wheat starch, tapioca starch, etc. Maltodextrin is widely used in candy, malted milk, fruit tea, milk powder, ice cream, beverage, can and other food, and is a filling material and a blending agent for various foods.
Citric acid: it is mainly used in food industry, such as sour agent, solubilizer, buffer, antioxidant, deodorizing agent, flavor enhancer, gelatinizer, and toner. The palatability of the ration can be improved. Citric acid can directly stimulate taste bud cells in oral cavity to increase salivary secretion, and has the functions of flavoring agent, enhancing animal appetite, decreasing acidity in stomach after eating, and converting inactive pepsinogen into active pepsin, or directly stimulating secretion of digestive enzyme; in addition, after the acidic chyme enters the small intestine, the small intestine is stimulated to secrete the gastrostatin, so that the gastrokinesia is reflectively inhibited, the gastric emptying time is delayed, the time of the chyme passing through the intestinal tract is prolonged, and the digestion of nutrient substances is promoted. The citric acid reduces the pH value in the gastrointestinal tract, and probiotics such as lactobacillus and the like in the intestinal tract obtain good growth conditions, so that the normal balance of microbial flora in the digestive tract is maintained. It has immunological monitoring effect on body. Research shows that citric acid can make immunocompetent cells have higher density, make the body in a better immune state, inhibit propagation of intestinal pathogenic bacteria and prevent infectious diseases. Citric acid is a natural preservative, has obvious mildew-proof effect, and prolongs the storage period of food.
(III) advantageous effects
Compared with the prior art, the invention provides the ginkgo and cordyceps militaris granules capable of conditioning blood pressure, and the ginkgo and cordyceps militaris granules have the following beneficial effects:
the invention skillfully utilizes the effects of promoting blood circulation and removing blood stasis of various components in the formula, can effectively clear and dredge blood vessels, change microcirculation, restore blood vessel elasticity, clear harmful substances accumulated in the blood vessels for a long time, improve blood supply of heart and brain and blood vessels and regulate blood pressure, eliminate microcirculation disturbance and fully improve the blood vessel environment of human bodies, adds vital energy-strengthening and constitution-consolidating medicines such as cordyceps militaris, ginseng, Chinese yam and the like into the ingredients, can fully improve the body function and the immunity and disease resistance, fully utilizes the convenience characteristic of medicinal granules, is convenient to take and drink after being infused in water, is convenient to fully utilize and absorb by the human bodies, plays the maximum value, exerts the synergistic effect among the components to form mutual assistance and complementation, can obviously sense energy improvement, improve the immunity and disease resistance and increase the cardiac muscle function after being absorbed by the human bodies, The health-care tea has the advantages of promoting vasodilatation, accelerating blood circulation, smoothing blood flow, convenient use, and no toxic or side effect, and is suitable for long-term drinking.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Examples
One embodiment of the invention provides:
the ginkgo and cordyceps militaris granules capable of regulating blood pressure comprise the following components in parts by weight: 10 parts of ginkgo powder, 5 parts of Chinese date, 11 parts of cordyceps militaris, 10 parts of ginseng, 7 parts of medlar, 3 parts of white gourd, 3 parts of cassia seed, 6 parts of kudzu root, 6 parts of chrysanthemum, 5 parts of Chinese yam, 2 parts of corn stigma, 1 part of rhizoma polygonati, 1 part of gardenia, 1 part of hawthorn, 0.5 part of mint, 0.1 part of maltodextrin and 0.1 part of citric acid;
the ginseng is artificially planted for five years or less, so that the ginseng has high medicinal and edible nutritive value, is convenient to purchase on the market and has lower price;
wherein, the formula comprises the following raw materials: the ginkgo powder, the Chinese dates, the cordyceps militaris, the ginseng, the medlar, the white gourd, the cassia seeds, the kudzu roots, the chrysanthemum, the Chinese yam, the corn stigma, the sealwort, the gardenia, the hawthorn and the mint are dried and ground into powder, the powder is screened and then fully mixed, and the mixture is subpackaged, so that the electuary prepared from the powder is convenient to drink directly after being mixed with water, and the practical convenience is improved while the instant powder is convenient to absorb by a human body;
the instant granules are not suitable for infants, pregnant women, lactating women, children under 14 years old and practical fungus allergic persons to eat, and are sealed and stored in cool and dry places after being subpackaged, so that the optimal edible effect is ensured, and the instant granules are convenient for absorption and utilization by human bodies after being eaten.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (4)
1. The gingko and cordyceps militaris granules capable of regulating blood pressure are characterized by comprising the following formula raw materials: ginkgo powder, Chinese date, cordyceps militaris, ginseng, medlar, white gourd, cassia seed, kudzu root, chrysanthemum, Chinese yam, corn stigma, sealwort, gardenia, hawthorn, mint, maltodextrin and citric acid.
2. The gingko and cordyceps militaris granules capable of regulating blood pressure as claimed in claim 1, wherein the formula comprises the following components in parts by weight: 10 parts of ginkgo powder, 5 parts of Chinese date, 11 parts of cordyceps militaris, 10 parts of ginseng, 7 parts of medlar, 3 parts of white gourd, 3 parts of cassia seed, 6 parts of kudzu root, 6 parts of chrysanthemum, 5 parts of Chinese yam, 2 parts of corn stigma, 1 part of rhizoma polygonati, 1 part of gardenia, 1 part of hawthorn, 0.5 part of mint, 0.1 part of maltodextrin and 0.1 part of citric acid.
3. The gingko and cordyceps militaris granules capable of regulating blood pressure as claimed in claim 1, wherein: the ginseng is artificially planted for less than five years.
4. The gingko and cordyceps militaris granules capable of regulating blood pressure as claimed in claim 1, wherein: the formula comprises the following raw materials: the ginkgo powder, Chinese date, cordyceps militaris, ginseng, medlar, white gourd, cassia seed, kudzu root, chrysanthemum, Chinese yam, corn stigma, sealwort, gardenia, hawthorn and mint are dried and ground into powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111174479.7A CN113855766A (en) | 2021-10-09 | 2021-10-09 | Gingko and cordyceps militaris granules capable of regulating blood pressure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111174479.7A CN113855766A (en) | 2021-10-09 | 2021-10-09 | Gingko and cordyceps militaris granules capable of regulating blood pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113855766A true CN113855766A (en) | 2021-12-31 |
Family
ID=79001997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111174479.7A Pending CN113855766A (en) | 2021-10-09 | 2021-10-09 | Gingko and cordyceps militaris granules capable of regulating blood pressure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113855766A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114642236A (en) * | 2022-03-23 | 2022-06-21 | 广州高人汇生物科技有限公司 | Chlorella natto tablet candy capable of assisting in lowering blood pressure |
| CN115040612A (en) * | 2022-07-11 | 2022-09-13 | 陈淼娟 | Composition for regulating hypertension and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111419977A (en) * | 2020-05-14 | 2020-07-17 | 陈先亮 | Traditional Chinese medicine composition for regulating human blood pressure and preparation method thereof |
| CN112690390A (en) * | 2021-01-08 | 2021-04-23 | 江苏中堂健康管理有限公司 | Ginseng cordyceps militaris solid beverage and preparation method thereof |
| CN112931671A (en) * | 2021-03-29 | 2021-06-11 | 陈军 | Cordyceps peptide tablet candy and preparation method thereof |
-
2021
- 2021-10-09 CN CN202111174479.7A patent/CN113855766A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111419977A (en) * | 2020-05-14 | 2020-07-17 | 陈先亮 | Traditional Chinese medicine composition for regulating human blood pressure and preparation method thereof |
| CN112690390A (en) * | 2021-01-08 | 2021-04-23 | 江苏中堂健康管理有限公司 | Ginseng cordyceps militaris solid beverage and preparation method thereof |
| CN112931671A (en) * | 2021-03-29 | 2021-06-11 | 陈军 | Cordyceps peptide tablet candy and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 佚名: "《胜奥延生公众号》", 10 April 2021 * |
| 孙秀峰等: "益心脑冲剂的制备与应用", 《山东医药工业》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114642236A (en) * | 2022-03-23 | 2022-06-21 | 广州高人汇生物科技有限公司 | Chlorella natto tablet candy capable of assisting in lowering blood pressure |
| CN115040612A (en) * | 2022-07-11 | 2022-09-13 | 陈淼娟 | Composition for regulating hypertension and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (en) | Drinks containing red ginseng and antler extract and preparation method thereof | |
| CN101744170B (en) | Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof | |
| CN102511869B (en) | Thickened red jujube ginger pulp | |
| CN107296949A (en) | Integration of drinking and medicinal herbs compound formulation and its preparation method and application | |
| CN102511867B (en) | Red jujube donkey-hide gelatin thick syrup | |
| CN103725572B (en) | A kind of preparation method of Korean red ginseng wine | |
| CN108244633A (en) | A kind of health-care food composition of clearing damp invigorating the spleen and preparation method thereof | |
| CN101669624B (en) | Chinese medicinal assorted Chinese herbal tea with function of improving woman anemia and preparation method thereof | |
| CN101796979A (en) | Xylitol soybean milk and preparation method thereof | |
| CN113855766A (en) | Gingko and cordyceps militaris granules capable of regulating blood pressure | |
| CN105233140A (en) | Acanthopanax sessiliflorus composition with spleen invigorating and stomach benefiting functions, and preparation method thereof | |
| CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
| CN103749827B (en) | Preparation method of red ginseng/fig tea | |
| CN113749152A (en) | Health preserving and body building drink and preparation method thereof | |
| CN103695275A (en) | Method for preparing Korean-ginseng and sea cucumber wine | |
| KR20210041387A (en) | A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata | |
| CN101991110A (en) | Wild ganoderma lucidum food | |
| CN104187246A (en) | Functional brown sugar and preparation method thereof | |
| CN103584244A (en) | Preparation method of heat clearing and lung moistening beverage | |
| CN108813633A (en) | Wood frog ovum Gly-His-Lys | |
| CN114191515A (en) | A kind of oral gel for removing dampness and strengthening stomach and improving immunity and preparation method thereof | |
| CN102715241B (en) | Gorgon fruit milk custard as well as gorgon fruit lotus root starch and dried beancurd stick with comprehensive nutrition and spleen tonifying effect | |
| CN115040612A (en) | Composition for regulating hypertension and preparation method thereof | |
| CN105105127A (en) | Multifunctional health food of haw heart easing powder | |
| CN112568346A (en) | Health beverage with blood pressure lowering, blood sugar lowering and blood fat reducing effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211231 |
|
| RJ01 | Rejection of invention patent application after publication |